ONCOVERITY
Live / Applied — First extension granted (statement of use) (as of 20 Dec 2024)
What this means for you
Not registered yet, but its 11 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97790864
- Mark type
- Stylized text
- Filed
- 11 Feb 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- Richard Todd Armstrong, Ph.D.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for medical or clinical use in the field of cancer treatments
- Class 042 — Scientific and technological services: Medical and scientific research and development in the field of cancer
- Class 044 — Medical, beauty and agricultural services: Medical services
Owner
- OncoVerity, Inc., Aurora, CO, US
- OncoVerity, Inc., Aurora, CO, US
Prosecution history
- 18 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 26 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jun 2025 — TEAS STATEMENT OF USE RECEIVED
- 24 Jun 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Dec 2024 — SOU EXTENSION 1 GRANTED
- 20 Dec 2024 — SOU EXTENSION 1 FILED
- 20 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 17 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED